Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT03088059
Title	Biomarker-based Study in R/M SCCHN (UPSTREAM)
Acronym	UPSTREAM
Recruitment	Active, not recruiting
Gender	both
Phase	Phase II
Variant Requirements	Yes
Sponsors	European Organisation for Research and Treatment of Cancer - EORTC
Indications	head and neck squamous cell carcinoma
Therapies	Niraparib Durvalumab + Monalizumab Methotrexate Carboplatin Rogaratinib Mitomycin C Docetaxel Afatinib Paclitaxel Durvalumab Monalizumab Palbociclib Bleomycin Gemcitabine Fluorouracil
Age Groups:	senior \| adult
Covered Countries	ITA \| GBR \| FRA \| ESP \| BEL